Powder: -20°C for 3 years | In solvent: -80°C for 1 year
N-Acetylhexosamine kinase (NahK) acts as an anomeric kinase, primarily catalyzing the phosphorylation of GlcNAc or GalNAc at their anomeric C1 positions using ATP. This process results in the formation of N-acetylhexosamine 1-phosphate (GlcNAc-1P/GalNAc-1P), operating on glucose-type substrates [1] [2].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | N-Acetylhexosamine kinase (NahK) acts as an anomeric kinase, primarily catalyzing the phosphorylation of GlcNAc or GalNAc at their anomeric C1 positions using ATP. This process results in the formation of N-acetylhexosamine 1-phosphate (GlcNAc-1P/GalNAc-1P), operating on glucose-type substrates [1] [2]. |
Molecular Weight | N/A |
CAS No. | 1609980-80-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
N-Acetylhexosamine kinase (NahK) 1609980-80-4 inhibitor inhibit